FME

Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care

Retrieved on: 
Friday, March 22, 2024
Inclusion, Fresenius Medical Care, Letter, Science Based Targets initiative, Kidney, Patient, UN Women, Climate, Diversity, Science, Woman, Patient satisfaction, Annual report, The Annual Report, Dialysis, FME, BAD, German, Paris Agreement

Titled "Shaping the Future of Kidney Care," the report provides detailed information about Fresenius Medical Care's economic, social and environmental performance in 2023.

Key Points: 
  • Titled "Shaping the Future of Kidney Care," the report provides detailed information about Fresenius Medical Care's economic, social and environmental performance in 2023.
  • Helen Giza, CEO and Chair of the Management Board of Fresenius Medical Care AG, said: "The year 2023 was a transformative one for Fresenius Medical Care, as we set out to achieve important structural, operational, and cultural changes.
  • The 2023 Annual Report summarizes Fresenius Medical Care's steps to successfully deliver on the transformation and contains Fresenius Medical Care's Non-financial Group Report, providing a comprehensive overview of its progress of sustainability activities and achievements in three strategic focus areas:
    Enhancing quality care and access to health care: In about 4,000 dialysis clinics in around 50 countries worldwide, Fresenius Medical Care provided care for over 332,000 patients in 2023.
  • It is available for download as pdf-file on the company's website: Annual reports | Fresenius Medical Care .

Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device

Retrieved on: 
Tuesday, March 19, 2024
Ready4, Fresenius Medical Care, Learning, Safety, Kidney, Augmented reality, Education, Knowledge, Hospital, Emergency medicine, Augment, Intensive care medicine, Dialysis, FME, BAD, ICU, Nursing, Health, Medtech

The glasses stream visual and acoustic recordings as users interact with the dialysis machine, providing professionals with an immersive learning experience.

Key Points: 
  • The glasses stream visual and acoustic recordings as users interact with the dialysis machine, providing professionals with an immersive learning experience.
  • Our innovative solution is designed to ensure that nursing staff, particularly those in Intensive Care Units, are equipped with the knowledge needed to provide high-quality and exceptional patient care," says Dr. Katarzyna Mazur-Hofsäß, member of the Management Board of Fresenius Medical Care AG and responsible for Care Enablement, Fresenius Medical Care's MedTech segment.
  • The AR glasses provide access to the Augmented Reality learning program Ready4 multiFiltratePRO AR, which Fresenius Medical Care presented today at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels.
  • Ready4 multiFiltratePRO AR has been specifically developed for use with the multiFiltratePRO, Fresenius Medical Care's Continuous Kidney Replacement Therapy system.

Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies

Retrieved on: 
Thursday, February 8, 2024
Health care, Dialysis, BAD, Hemofiltration, Kidney, Mortality, FDA, Food, Food and Drug Administration, Fresenius Medical Care, Convection, Diffusion, Engineering, Patient, Water, FME, Blood, Medical device

Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company's 5008X Hemodialysis System.

Key Points: 
  • Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company's 5008X Hemodialysis System.
  • This will enable Fresenius Medical Care to offer the industry-leading, high-volume hemodiafiltration (Hv-HDF) dialysis therapy – already widely used in Europe – for people living with kidney diseases in the U.S.
  • The 510(k) clearance allows the start of clinical evaluations and user-studies in the U.S., with a planned broad commercial launch of the 5008X Hemodialysis System in 2025.
  • The 5008X Hemodialysis System and companion FX CorAL dialyzer demonstrate the company's global innovation leadership in medical device and membrane engineering technologies.

Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board

Retrieved on: 
Monday, February 5, 2024
Supervisory board, Works council, BAD, Supervision, Fresenius Medical Care, Patient, Workforce, FME, IGBCE, Beata, Aktiengesellschaft, Sankt Wendel, Kidney, Woman

BAD HOMBURG, Germany, Feb. 5, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has nominated six employee representatives as members of the company's Supervisory Board.

Key Points: 
  • BAD HOMBURG, Germany, Feb. 5, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has nominated six employee representatives as members of the company's Supervisory Board.
  • Fresenius Medical Care successfully completed its change of legal form into a German stock corporation (Aktiengesellschaft, AG) on November 30, 2023, which also included the formation of a new Supervisory Board, which initially consisted of the six shareholder representatives.
  • The appointed members of the Supervisory Board are:
    Stefanie Balling, Chairwoman of the General Works Council of Fresenius Medical Care in Germany, and Chairwoman of the local works council at the Schweinfurt site (Care Enablement)
    Beate Haßdenteufel, Deputy Chairwoman of the Works Council at the St. Wendel site (Care Enablement)
    Michael Sen, Chairman of the Supervisory Board of Fresenius Medical Care AG, says: "The proposed employee representatives provide a broad range of experience and knowledge to the Supervisory Board.
  • Following the appointment, Fresenius Medical Care is preparing the election of the employee representatives to the Supervisory Board, following legal requirements.

Safe Software named a Niche Player in 2023 Gartner® Magic Quadrant™ for Data Integration Tools

Retrieved on: 
Monday, December 18, 2023
Magic, Entrepreneurship, Human voice, Research, FME, MAGIC, Customer, Publication, Magic Quadrant, Organization

Vancouver, BC, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Safe Software , a leader in data integration and transformation, is named a Niche Player in the 2023 Gartner® Magic Quadrant™ for Data Integration Tools, placing it among 21 total vendors evaluated in the report.

Key Points: 
  • Vancouver, BC, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Safe Software , a leader in data integration and transformation, is named a Niche Player in the 2023 Gartner® Magic Quadrant™ for Data Integration Tools, placing it among 21 total vendors evaluated in the report.
  • Additionally, Safe Software has been the innovator in spatial data for nearly 30 years with a global community of 200,000 passionate users bringing life to their data.
  • Read the full 2023 Gartner® Magic Quadrant™ for Data Integration Tools report here.
  • Gartner Reports: Gartner, Magic Quadrant for Data Integrations Tools, Ehtisham Zaidi, Robert Thanaraj, Sharat Menon, Roxane Edjlali, Thornton Craig December 4, 2023.

Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million - 2023 earnings outlook raised

Retrieved on: 
Tuesday, November 21, 2023
Frankfurt Stock Exchange, FME, Complaint, Kidney, Patient, Fresenius Medical Care, Nature, Element, Dialysis, KPI, Defense, COVID-19, Government, FMS, Pharmaceutical industry, Health insurance, Tricare

Tricare provides reimbursement for dialysis treatments and other medical care provided to members of the military services, their dependents and retirees.

Key Points: 
  • Tricare provides reimbursement for dialysis treatments and other medical care provided to members of the military services, their dependents and retirees.
  • Fresenius Medical Care therefore expects a net positive impact on operating income (guidance basis)1 of approx.
  • As a consequence of the settlement agreement, Fresenius Medical Care today raises its earnings outlook.
  • Through its network of 4,014 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 342,000 patients around the globe.

Fresenius Medical Care appoints Craig Cordola as new Management Board member for Care Delivery

Retrieved on: 
Tuesday, October 31, 2023
Kidney, Knowledge, Frankfurt Stock Exchange, FME, American College, Health administration, Financial Oversight and Management Board for Puerto Rico v. Aurelius Investment, LLC, Organization, Cyprus Securities and Exchange Commission, University of Houston–Clear Lake, Health, MBA, Lanny Cordola, Dialysis, Ascension, Supervisory board, Memorial Hermann Health System, COVID-19, Business administration, Retirement, Fresenius Medical Care, University of Texas at Austin, University, MHA, Master of Business Administration, Patient, FMS, Pharmaceutical industry, Nursing, Psychology

WALTHAM, Mass., Oct. 31, 2023 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has appointed Craig Cordola (52) as new Management Board member for the globally operating Care Delivery segment.

Key Points: 
  • WALTHAM, Mass., Oct. 31, 2023 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has appointed Craig Cordola (52) as new Management Board member for the globally operating Care Delivery segment.
  • Michael Sen, Chairman of the Supervisory Board of Fresenius Medical Care Management AG, said: "We are delighted to have Craig Cordola join the Management Board of Fresenius Medical Care as the leader of the global Care Delivery organization.
  • With this expertise, he will be a crucial player in the Management Board in implementing Fresenius Medical Care's turnaround and focusing on patient care."
  • Craig Cordola said: "I am excited to join Fresenius Medical Care, the global leader in kidney care and leading healthcare brand across this industry.

Fresenius Medical Care Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023

Retrieved on: 
Tuesday, October 31, 2023
Kidney, Frankfurt Stock Exchange, Patient, Hemofiltration, Research, FME, Intelligence, III, HDF, Assessment of kidney function, AVF, Big data, Fatigue, HD, American Society of Nephrology, Saskatchewan River Sturgeon Management Board, Arteriovenous fistula, FX, Health, Society, Artificial intelligence, Dialysis, PO4, PSM, COVID-19, ASN, Machine learning, Congress, Fresenius Medical Care, FKC, RBV, Creatinine, Scientific Committee on Oceanic Research, FMS, Peritoneum, IDS, Data science, Pharmaceutical industry, Medical device, Hemodialysis, Nephrology

Fresenius Medical Care announces presentations at the American Society of Nephrology (ASN) Kidney Week 2023.

Key Points: 
  • Fresenius Medical Care announces presentations at the American Society of Nephrology (ASN) Kidney Week 2023.
  • Scientific and medical experts from across Fresenius Medical Care will present research related to many important topics in kidney disease care.
  • Through its network of 4,050 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 344,000 patients around the globe.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius Medical Care Achieves Key AI Milestone With First-Phase Completion of Largest Global Dialysis Clinical Dataset

Retrieved on: 
Thursday, October 26, 2023
Cloud, Kidney, Knowledge, Frankfurt Stock Exchange, Global Medical Device Nomenclature, FME, Innovation, HIPAA, Physician, MD, Saskatchewan River Sturgeon Management Board, Doctor of Philosophy, Health, Research, Society, Artificial intelligence, Quality of life, Digital technology, Dialysis, Database, COVID-19, Medicine, Fresenius Medical Care, Kidney disease, Privacy, AI, Patient, FMS, GDPR, Medical imaging, Medical device, Pharmaceutical industry

"The data created across Fresenius Medical Care's global clinical footprint is unmatched in its breadth and depth, and is one of the company's greatest competitive advantages," said Stuart McGuigan, Global Chief Information Officer of Fresenius Medical Care.

Key Points: 
  • "The data created across Fresenius Medical Care's global clinical footprint is unmatched in its breadth and depth, and is one of the company's greatest competitive advantages," said Stuart McGuigan, Global Chief Information Officer of Fresenius Medical Care.
  • Through its network of 4,050 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 344,000 patients around the globe.
  • Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Unveiling the Integration: Sphere and Safe Software's Spatial Collaboration Tool with Key Enterprise Applications at Augmented Enterprise Summit 2023

Retrieved on: 
Monday, October 23, 2023
FME, Heart, Extended reality, CRMS, Organization, AM, Software, Partnership, XR, AES, Video game, Satellite navigation device, Sphere

Their joint effort will be showcased at the Augmented Enterprise Summit (AES) in Houston, on October 25th, 2023 at Safe Software's booth, from 10:35 AM - 11:35 AM CST.

Key Points: 
  • Their joint effort will be showcased at the Augmented Enterprise Summit (AES) in Houston, on October 25th, 2023 at Safe Software's booth, from 10:35 AM - 11:35 AM CST.
  • This partnership shows the power of Sphere's device agnostic augmented reality platform and Safe Software's FME data integration platform.
  • At the heart of this collaboration is the ability to make augmented reality technology accessible and scalable within an enterprise setting.
  • Safe Software's FME data integration platform serves as a conduit for various data sources, enhancing the immersive experience for Sphere users.